ZA936723B - Pharmaceutical preparations for lowering homocysteine levels - Google Patents

Pharmaceutical preparations for lowering homocysteine levels

Info

Publication number
ZA936723B
ZA936723B ZA936723A ZA936723A ZA936723B ZA 936723 B ZA936723 B ZA 936723B ZA 936723 A ZA936723 A ZA 936723A ZA 936723 A ZA936723 A ZA 936723A ZA 936723 B ZA936723 B ZA 936723B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical preparations
homocysteine levels
lowering homocysteine
lowering
levels
Prior art date
Application number
ZA936723A
Other languages
English (en)
Inventor
Willem Jacob Serfontein
Original Assignee
Vesta Med Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vesta Med Pty Ltd filed Critical Vesta Med Pty Ltd
Publication of ZA936723B publication Critical patent/ZA936723B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7135—Compounds containing heavy metals
    • A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
ZA936723A 1992-09-14 1993-09-13 Pharmaceutical preparations for lowering homocysteine levels ZA936723B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA926990 1992-09-14

Publications (1)

Publication Number Publication Date
ZA936723B true ZA936723B (en) 1995-08-14

Family

ID=25582104

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA936723A ZA936723B (en) 1992-09-14 1993-09-13 Pharmaceutical preparations for lowering homocysteine levels

Country Status (5)

Country Link
EP (1) EP0595005A1 (xx)
JP (1) JPH06192105A (xx)
CN (1) CN1087517A (xx)
CA (1) CA2105177A1 (xx)
ZA (1) ZA936723B (xx)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0689834A3 (en) 1994-07-01 1996-06-05 Willem Jacob Serfontein Food or feed additive that contains vitamins and minerals with delayed release of active ingredients
EP0781142A4 (en) * 1994-09-01 2003-04-09 Allied Medical Res Associates COMPOSITIONS AND METHOD FOR PROVIDING POLYPEPTIDES
US5932624A (en) * 1995-10-17 1999-08-03 Herbert; Victor D. Vitamin supplement composition
US6265391B1 (en) 1995-10-17 2001-07-24 Upsher-Smith Laboratories, Inc. Method for preventing peripheral nerve damage
US5997915A (en) 1996-01-31 1999-12-07 South Alabama Medical Science Foundation Compositions for human and animal consumption containing reduced folates and methods for making and using same
DE19649730A1 (de) * 1996-08-08 1998-02-12 Eu Rho Pharma Gmbh Mittel zur Stärkung des menschlichen Organismus
US6008221A (en) * 1996-11-06 1999-12-28 Bristol-Myers Squibb Company Method for treating Alzheimer's disease with folic acid
CH693255A5 (de) * 1997-06-13 2003-05-15 Eprova Ag Verwendung von Tetrahydrofolaten in der natürlichenstereoisomeren Form zur Herstellung einer pharmazeutischenZubereitung geeignet zur Beeinflussung des Homocystein-Spiegels.
DE19812753C1 (de) * 1998-03-23 1999-09-09 Schieffer Arzneimittel Gmbh Dr Zusammensetzung zur pharmazeutischen Anwendung und/oder zur Ernährungsergänzung bei Mensch oder Tier
US6541680B1 (en) * 1998-06-12 2003-04-01 Craig Anthony Cooney Nutritional methyl supplements change DNA methylation and related characteristics of mammalian offspring
US6475514B1 (en) 1998-12-03 2002-11-05 Andrew Blitzer Athletic patch
US6210686B1 (en) * 1998-12-18 2001-04-03 Beth Israel Deaconess Medical Center Dietary supplement and method for lowering risk of heart disease
US6914073B2 (en) * 1999-03-18 2005-07-05 Bristol Myers Squibb Company Vitamin formulation for cardiovascular health
GB9906740D0 (en) 1999-03-23 1999-05-19 Kilgowan Limited Oral combinations of hydroxocobalamin and folic acid
BR0013719A (pt) * 1999-09-02 2002-07-23 Nostrum Pharmaceuticals Inc Dosagem oral de liberaçâo controlada, apropriada para administração oral
FI19992239A (fi) * 1999-10-18 2001-04-19 Jurilab Ltd Oy Ravintotäydennys
AU1243101A (en) * 1999-10-28 2001-05-08 Cary Pharmaceuticals Inc. High dose folic acid for the treatment of hyperhomocysteinemia
DE10053155A1 (de) * 2000-10-26 2002-05-08 Erika Jungkeit Verwendung eines Multivitaminpräparats zur Behandlung der Schuppenflechte
JP2004538262A (ja) * 2000-12-14 2004-12-24 タフツ ユニバーシティー 関節炎状態を治療するための化合物および方法
CN100341509C (zh) * 2002-07-11 2007-10-10 三共株式会社 用于改善血液中脂质或降低血液中高半胱氨酸的药物组合物
JP4611622B2 (ja) * 2002-07-11 2011-01-12 第一三共株式会社 血中脂質改善又は血中ホモシステイン低下のための医薬組成物
JP2004231585A (ja) * 2002-12-05 2004-08-19 Fancl Corp 生体内ホモシステインレベル低減用および上昇抑制用組成物
EP1937269A1 (en) * 2004-05-09 2008-07-02 Amal Mohamed Zakaria Al-Ansary Process for the production of contraceptive formulations
US20050272691A1 (en) * 2004-06-04 2005-12-08 Eaton Kevin P Treatment of dermatological conditions
DE102005001479A1 (de) * 2005-01-12 2006-07-20 Synavit Gmbh Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung
DE102005009379A1 (de) 2005-03-01 2006-09-07 Synavit Gmbh Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung
CN100349578C (zh) * 2005-04-29 2007-11-21 朱舜时 治疗萎缩性胃炎的药物组合物
JP2007106703A (ja) * 2005-10-14 2007-04-26 Nutri Kk 血管障害の予防および治療組成物
US7282225B1 (en) 2006-09-27 2007-10-16 Occular Technologies, Inc. Composition and methods for improving retinal health
DE102007003795A1 (de) * 2007-01-25 2008-07-31 Phrontier S.A.R.L. Verwendung von Folsäure, Vitamin B6 und Vitamin B12
ES2664826T3 (es) 2007-10-25 2018-04-23 Nutri Co., Ltd. Composición para reducir el nivel glucosa, LDL modificada con malondialdehído, homocisteína y/o proteína c-reactiva en sangre
CN101584380B (zh) * 2009-06-19 2011-08-10 山西新立源生物科技有限公司 复合甜菜碱的制备方法
CN102898321B (zh) * 2011-07-24 2015-10-28 上海海嘉诺医药发展股份有限公司 一种制备n-丁氧草酰丙氨酸丁酯的方法
CN102429920A (zh) * 2011-11-30 2012-05-02 胡志超 一种多关联降血酸组合物及其制备方法
EP2674159B1 (de) * 2012-06-15 2016-04-27 Phrontier S.A.R.L. Pharmazeutische Zusammensetzung für die Leber-Regeneration
CN115778979A (zh) * 2015-10-07 2023-03-14 帝斯曼知识产权资产管理有限公司 多维生素挤出物
BR112018069285A2 (pt) * 2016-03-22 2019-01-22 Balchem Corp composições compreendendo colina
US11291683B2 (en) 2016-04-01 2022-04-05 Access Business Group International Llc Bilayer tablets of B vitamins and process for preparing the same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES367284A1 (es) * 1968-05-16 1971-04-01 Merck Ag E Procedimiento para la obtencion de preparados de vitaminas solidos.
GB8900924D0 (en) * 1989-01-17 1989-03-08 Amco Chemie Handel Compositions for use in enzyme deficiencies
NZ222664A (en) * 1986-11-29 1990-06-26 Vesta Med Pty Ltd Pharmaceutical compositions containing pyridoxal as a source of vitamin b6
DE69124223T2 (de) * 1990-02-05 1997-04-30 Lifescience Corp Vitamine und mineralien enthaltende nahrungszusätze
GB2254556B (en) * 1991-04-11 1995-04-12 Fisons Plc Formulations containing linolenic acid

Also Published As

Publication number Publication date
EP0595005A1 (en) 1994-05-04
CN1087517A (zh) 1994-06-08
CA2105177A1 (en) 1994-03-15
JPH06192105A (ja) 1994-07-12

Similar Documents

Publication Publication Date Title
ZA936723B (en) Pharmaceutical preparations for lowering homocysteine levels
PH30215A (en) Pharmaceutical compounds
GB9319500D0 (en) Pharmaceutical composition
HU9303261D0 (en) Pharmaceutical compounds
GB2272375B (en) Pharmaceutical composition
ZA931944B (en) Pharmaceutical compounds
GB9201639D0 (en) Pharmaceutical formulations
GB9221707D0 (en) Pharmaceutical composition
PL308307A1 (en) 3-substituted 2-oxyindolo-1-carboxylamide pharmaceutical preparations
GB9222242D0 (en) Pharmaceutical preparations for lowering homocysteine levels
ZA938546B (en) Pharmaceutical compounds
GB9226724D0 (en) Pharmaceutical compounds
ZA924061B (en) Pharmaceutical composition
GB9211379D0 (en) Pharmaceutical compounds
ZA931984B (en) Pharmaceutical composition
GB9222650D0 (en) Pharmaceutical compounds
GB9204302D0 (en) Pharmaceutical compounds
GB9209028D0 (en) Pharmaceutical compounds
GB9226895D0 (en) Pharmaceutical compounds
GB9213058D0 (en) Pharmaceutical compounds
GB9218090D0 (en) Pharmaceutical compounds
GB9218112D0 (en) Pharmaceutical compounds
GB9218092D0 (en) Pharmaceutical compounds
GB9218091D0 (en) Pharmaceutical compounds
GB9207338D0 (en) Pharmaceutical formulations